Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction

Elif Elmas; Parviz Ahmad-Nejad; Christel Weiss; Michael Neumaier; Martin Borggrefe

doi:10.1515/CCLM.2008.265

Published by De Gruyter September 1, 2008

Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction

Elif Elmas , Parviz Ahmad-Nejad , Christel Weiss , Michael Neumaier and Martin Borggrefe

From the journal Clinical Chemistry and Laboratory Medicine

https://doi.org/10.1515/CCLM.2008.265

Showing a limited preview of this publication:

Keywords: genetic polymorphisms; myocardial infarction; sudden cardiac death

a

Elif Elmas and Parviz Ahmad-Nejad contributed equally to this work.

Corresponding author: Dr. med. Elif Elmas, First Department of Medicine, University Hospital of Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany Phone: +49-621-383-2204, Fax: +49-621-383-3821, elif.elmas@med.ma.uni-heidelberg.de

Published Online: 2008-09-01

Published in Print: 2008-09-01

Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction

Journal and Issue

Articles in the same Issue